HOME >> MEDICINE >> NEWS
UCSF Recruting Breast Cancer Patients For Herbal Therapy Study

Researchers at the University of California San Francisco are recruiting patients for the first study in the U.S. that will determine the feasibility of using Chinese herbal therapy to alleviate the side effects of chemotherapy in women with early stage breast cancer.

Developed in collaboration at UCSF with Western breast cancer investigators and practitioners as well as non-Western herbalists, this study aims to scientifically evaluate the benefits of a Chinese herbal formula that is widely used by herbalists for cancer patients receiving chemotherapy. In addition, the trial will assess any toxicities associated with the use of the formula in conjunction with chemotherapy.

After conferring with many herbalists around the world, studying past clinical trials of herbal therapies, and reading text books on the subject, UCSF researchers developed a formula consisting of a range of herbs that they hope will alleviate multiple side effects of chemotherapy. The formula contains 21 herbs and has received an Investigational New Drug (IND) license from the Food and Drug Administration which is necessary to conduct a clinical trial.

This novel trial is a crucial first step to integrating traditional Chinese medicine, where effective, into the standard of care for breast cancer patients, UCSF researchers said.

"Ultimately, we would like to develop a model in which we integrate the parts of herbal therapies that are safe and effective with those that we know are effective in standard conventional therapy, such as chemotherapy," said Debu Tripathy, MD, UCSF associate professor of medicine, director of clinical research at the UCSF Carol Franc Buck Breast Care Center and principal investigator of the study.

In the U.S., most women are diagnosed with breast cancer at an early stage. Chemotherapy is being recommended more often as studies now show a clear reduction in the risk of cancer spread, Tripathy said. However, he added that the treatm
'"/>

Contact: Abby Sinnott
sinnott@itsa.ucsf.edu
415-885-7277
University of California - San Francisco
27-Oct-1998


Page: 1 2 3

Related medicine news :

1. Hausman to give keynote address at Breastfeeding, Motherhood and Feminism symposium
2. Breast implant Website launched by leading plastic surgery societies
3. Breast cancer treatment reduces risk of heart disease
4. Breast reconstruction with implants after mastectomy doesnt hurt survival chances
5. Breast cancer may be uniquely sensitive to inhibitors of PI3K pathway
6. Breast MRI moderately useful for detecting breast cancer, but does not eliminate need for biopsy
7. Breast conserving therapy safe for hereditary breast cancer
8. Breast cancer risk, prognosis and weight gain reduced with physical activity
9. Breast cancer in Asian Americans is rising faster than in any other ethnic group
10. Long Island Breast Cancer Study data: Aspirin helps protect some women against breast cancer
11. Breast cancer in men increasing

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCSF Recruting Breast Cancer Patients For Herbal Therapy Study

(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma Applied ... Mesothelioma Patient Registry Act of 2015’. The bill was introduced in Congress yesterday ... (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston Web Marketing ... All-Stars Summit. Google Partners is the platform for search marketing agencies to communicate ... and tools necessary to run successful search marketing campaigns. Google Partners also affords ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ocean Hills Recovery has officially been accredited by ... recommendations.” No recommendations means CARF found no areas in the OHR program that needed ... 3% of all facilities receive. In addition, Ocean Hills was granted the maximum certification ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, ... ... of Medicine at Mount Sinai Earns National Cancer Institute Designation , The Tisch ... been named a National Cancer Institute (NCI)-designated cancer center. TCI joins an elite ...
(Date:7/30/2015)... ... July 30, 2015 , ... 1Heart Caregiver Services LLC is offering its ... Make Money in the Booming Homecare Business.” This will be held in its main ... , The event will be hosted by 1Heart’s very own Randy Clarito (Director of ...
Breaking Medicine News(10 mins):Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2
(Date:7/30/2015)... 30, 2015  Alimera Sciences, Inc. (NASDAQ: ALIM ... research, development and commercialization of prescription ophthalmic pharmaceuticals, today ... year 2015 financial results after the market close on ... follow on the same day at 4:30 p.m. ET. ... Chief Executive Officer, and Rick Eiswirth , Chief ...
(Date:7/30/2015)... , Net Sales of $1.17 billion represent a decrease of ... of 5.7% constant currency , Reported net loss per ... per share were $1.59, an increase of 0.6% over the ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ...  The Company reported second quarter net sales of $1.17 billion, ...
(Date:7/29/2015)... Ill. , July 30, 2015  Astellas ... ACTIVE study evaluating the efficacy and safety of ... CRESEMBA® (isavuconazonium sulfate), under development for adults with ... Results from the study demonstrated that the trial ... in overall treatment response in isavuconazole-treated patients at ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 3Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 4Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 5Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 6Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 7Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 8Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 9Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 10Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 11Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 12Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 13Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 14Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 15Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 16Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 17Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 18Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 19Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 20Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 21Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 22Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 23Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 24Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 25Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 26Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 27Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 28Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 29Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5
Cached News: